VNOV
VitaNova Life Sciences CorpCompany Information
- Company Name
- VitaNova Life Sciences Corp
- CIK
- CIK0001699709
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- VNOV: OTC
- Fiscal Year End
- April 30
- Owner Organization
- 07 Trade & Services
- SIC
- 5130
- SIC Description
- Wholesale-Apparel, Piece Goods & Notions
- Ticker
- VNOV
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- —
- Institutional shares owned
- —
- Shares outstanding
- —
- Ownership
- —
Earnings Market Reaction
- Filing date
- 2026-09-14
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-07-31 | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 | 2023-10-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | - | - | - | - | - | - | - | - | - | - | 1 | 0 | ||||||
| Other Receivables Net Current | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
| Cash | 2 | 2 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | - | - | ||||||
| Accounts Receivable Net Current | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | - | 0 | - | - | ||||||
| Nontrade Receivables Current | - | - | - | - | - | - | - | - | - | 0 | - | - | ||||||
| Prepaid Expense Current | - | - | - | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Assets Current | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Deferred Income Tax Assets Net | - | 0 | - | - | - | 0 | - | - | - | - | - | - | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable And Accrued Liabilities Current | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Assets Noncurrent | - | 0 | - | - | - | 0 | - | - | - | - | - | - | ||||||
| Assets | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Accounts Payable Current | 0 | 0 | 0 | 0 | - | 0 | - | - | - | - | - | - | ||||||
| Deferred Revenue Current | - | - | - | 0 | 0 | - | - | - | - | - | - | - | ||||||
| Other Liabilities Current | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Accrued Liabilities Current | 0 | 0 | 0 | 0 | - | 0 | - | - | - | - | - | - | ||||||
| Taxes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | ||||||
| Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Value | 0 | 0 | 0 | - | - | 0 | - | - | - | - | - | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Retained Earnings Accumulated Deficit | 1 | 1 | 1 | 1 | 1 | 1 | 0 | -0 | -0 | 0 | -0 | -0 | ||||||
| Stockholders Equity | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | -0 | ||||||
| Liabilities And Stockholders Equity | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | - | - | - | 0.00 | - | - | - | - | - | - | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | - | - | - | 10 | - | - | - | - | - | - | ||||||
| Preferred Stock Shares Issued | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Preferred Stock Shares Outstanding | 0 | - | - | - | - | - | - | - | - | - | - | - | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 200 | 200 | - | 75 | 75 | 200 | 75 | 75 | 75 | 75 | 75 | 75 | ||||||
| Common Stock Shares Issued | - | 8 | - | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 2 | ||||||
| Shares Outstanding | 8 | 8 | - | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 2 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialVitaNova Life Sciences Corp (VNOV) — SEC Financial Statements & Analysis
VitaNova Life Sciences Corp (VNOV) is a wholesale-apparel, piece goods & notions company, incorporated in NV. VitaNova Life Sciences Corp trades on OTC as: VNOV. VitaNova Life Sciences Corp (VNOV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-07-31, filed with the SEC on 2026-09-14. Based on that filing, On profitability, VitaNova Life Sciences Corp posts a gross margin of 26.90%, an operating margin of -2.66%, a net margin of -3.52%, a Return on Equity (ROE) of -6.02%, a Return on Assets (ROA) of -5.09%, and a Return on Invested Capital (ROIC) of -13.70%. Per share, it reports EPS of $-0.01, diluted EPS of $0.09, free cash flow per share of $0.07, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 22.04% year-over-year, net income growth of -113.27% year-over-year, and EPS growth of -113.27% year-over-year. On the balance sheet, it maintains a current ratio of 7.13x, a quick ratio of 6.17x, working capital of $1.91M, a debt-to-equity ratio of 0.16x, a debt ratio of 0.14, an interest coverage ratio of 733.61x, free cash flow of $557.56K (TTM), and net debt of $-1.60M. Figures sourced from SEC EDGAR.
- EPS TTM
- $-0.01
- ROE TTM
- -6.02%
- ROA TTM
- -5.09%
- Debt To Equity
- 0.16x
- Free Cash Flow TTM
- $557.56K
- Net Revenue TTM Growth 1Y
- 22.04%
Data as of 2026-07-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is VitaNova Life Sciences Corp in?
VitaNova Life Sciences Corp (VNOV) operates in the Wholesale-Apparel, Piece Goods & Notions industry.
What exchange does VNOV trade on?
VitaNova Life Sciences Corp (VNOV) trades on the OTC.
Where is VitaNova Life Sciences Corp incorporated?
VitaNova Life Sciences Corp is incorporated in NV.
When was VitaNova Life Sciences Corp (VNOV)'s most recent SEC filing?
VitaNova Life Sciences Corp (VNOV)'s most recent SEC filing is a Form 10-Q for the period ended 2026-07-31, filed with the SEC on 2026-09-14.
What is VNOV's EPS (earnings per share)?
VitaNova Life Sciences Corp (VNOV)'s trailing twelve month EPS is $-0.01 as of 2026-07-31.
What is VNOV's ROE (return on equity)?
VitaNova Life Sciences Corp (VNOV)'s trailing twelve month Return on Equity (ROE) is -6.02% as of 2026-07-31.
What is VNOV's ROA (return on assets)?
VitaNova Life Sciences Corp (VNOV)'s trailing twelve month Return on Assets (ROA) is -5.09% as of 2026-07-31.
What is VNOV's ROIC (return on invested capital)?
VitaNova Life Sciences Corp (VNOV)'s trailing twelve month Return on Invested Capital (ROIC) is -13.70% as of 2026-07-31.